Verteporfin 15 mg Injection
RxNorm 313595
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 313595 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: verteporfin 15 mg Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
Semantic Clinical Drug (SCD):
Verteporfin 15 mg Injection
(Atom ID: 12350271)
Full form of descriptor (FN):
Product containing precisely verteporfin 15 mg/1 vial powder for conventional release solution for infusion (clinical drug)
(Atom ID: 12757524)
Full form of descriptor (FN):
Product containing precisely verteporfin 15 mg/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)
(Atom ID: 12757525)
Full form of descriptor (FN):
Product containing precisely verteporfin 15 mg/1 vial powder for conventional release solution for injection (clinical drug)
(Atom ID: 10318299)
Prescribable Name (PSN):
Verteporfin 15 mg Injection
(Atom ID: 8717341)
Designated preferred name (PT):
Verteporfin 15 mg powder for solution for infusion and/or injection vial
(Atom ID: 12757884)
Designated preferred name (PT):
Verteporfin 15 mg powder for solution for infusion vial
(Atom ID: 12757885)
Designated preferred name (PT):
Verteporfin 15 mg powder for solution for injection vial
(Atom ID: 10322303)
Patient Education
Verteporfin Injection
Verteporfin injection is used in combination with photodynamic therapy (PDT; treatment with a laser light) to treat abnormal growth of leaky blood vessels in the eye caused by wet age-related macular degeneration (AMD; an ongoing disease of the eye that causes loss of the ability to see straight ahead and may make it more difficult to read, drive, or perform other daily activities), pathologic myopia (a serious form of nearsightedness that worsens with time), or histoplasmosis (a fungal infection) of the eye. Verteporfin is in a class of medications called photosensitizing agents. When verteporfin is activated by light, it closes up the leaking blood vessels.
[Learn More]
Cancer Chemotherapy
Normally, your cells grow and die in a controlled way. Cancer cells keep growing without control. Chemotherapy is drug therapy for cancer. It works by killing the cancer cells, stopping them from spreading, or slowing their growth. However, it can also harm healthy cells, which causes side effects.
You may have a lot of side effects, some, or none at all. It depends on the type and amount of chemotherapy you get and how your body reacts. Some common side effects are fatigue, nausea, vomiting, pain, and hair loss. There are ways to prevent or control some side effects. Talk with your health care provider about how to manage them. Healthy cells usually recover after chemotherapy is over, so most side effects gradually go away.
Your treatment plan will depend on the cancer type, the chemotherapy drugs used, the treatment goal, and how your body responds. Chemotherapy may be given alone or with other treatments. You may get treatment every day, every week, or every month. You may have breaks between treatments so that your body has a chance to build new healthy cells. You might take the drugs by mouth, in a shot, as a cream, or intravenously (by IV).
NIH: National Cancer Institute
[Learn More]
* Please review the disclaimer below.
